Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RAC2 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → RAC2 |
| (<<) DAZAP2 → RAC2 |
| (<<) HSP90AB1 → RAC2 |
| (<<) INPP5D → RAC2 |
| (<<) MCL1 → RAC2 |
| (<<) PLD3 → RAC2 |
| (<<) RHOA → RAC2 |
| (<<) TPP1 → RAC2 |
| Downstream (Children) |
|---|
| RAC2 → ADRBK1 (>>) |
| RAC2 → ASB2 (>>) |
| RAC2 → CD4 (>>) |
| RAC2 → CD79A (>>) |
| RAC2 → CORO1A (>>) |
| RAC2 → DUSP7 (>>) |
| RAC2 → EHD1 (>>) |
| RAC2 → ELF1 (>>) |
| RAC2 → GLRX (>>) |
| RAC2 → GRN (>>) |
| RAC2 → GSTK1 (>>) |
| RAC2 → GYPC (>>) |
| RAC2 → HLA-G (>>) |
| RAC2 → IFITM3 (>>) |
| RAC2 → ITGB7 (>>) |
| RAC2 → ITPR1 (>>) |
| RAC2 → JAK1 (>>) |
| RAC2 → LCP1 (>>) |
| RAC2 → LTB (>>) |
| RAC2 → MAL (>>) |
| RAC2 → MPP1 (>>) |
| RAC2 → MYO10 (>>) |
| RAC2 → NFATC3 (>>) |
| RAC2 → NFKB1 (>>) |
| RAC2 → NFKB2 (>>) |
| RAC2 → PIK3CG (>>) |
| RAC2 → PRKACB (>>) |
| RAC2 → PTAFR (>>) |
| RAC2 → RASD1 (>>) |
| RAC2 → RHOF (>>) |
| RAC2 → SMAD2 (>>) |
| RAC2 → STAT1 (>>) |
| RAC2 → TGFB1 (>>) |
| RAC2 → TINF2 (>>) |
| RAC2 → TXNIP (>>) |
| RAC2 → UBE2L6 (>>) |
| RAC2 → VAV1 (>>) |
